These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 2593493

  • 21. Effect of ultraviolet-B-irradiated donor-specific blood transfusions and peritransplant immunosuppression with cyclosporine on rat cardiac allograft survival.
    Oluwole SF, Lau HT, Reemtsma K, Hardy MA.
    Transplantation; 1988 Feb; 45(2):293-7. PubMed ID: 3278417
    [Abstract] [Full Text] [Related]

  • 22. Kidney transplantation from living unrelated donors.
    Alfani D, Pretagostini R, Bruzzone P, Smits J, Persijn G, Cortesini R.
    Clin Transpl; 1998 Feb; ():205-12. PubMed ID: 10503099
    [Abstract] [Full Text] [Related]

  • 23. Renal transplantation: cyclosporin A and antibody development after donor-specific transfusion.
    al-Muzairai IA, Innes A, Hillis A, Stewart KN, Bone JM, Catto GR, Macleod AM.
    Kidney Int; 1989 Apr; 35(4):1057-63. PubMed ID: 2651767
    [Abstract] [Full Text] [Related]

  • 24. Renal transplants from HLA-haploidentical living-related donors. The influence of donor-specific transfusions and different immunosuppressive regimens.
    Leivestad T, Albrechtsen D, Flatmark A, Thorsby E.
    Transplantation; 1986 Jul; 42(1):35-8. PubMed ID: 3523880
    [Abstract] [Full Text] [Related]

  • 25. Efficacy of a single pretransplant donor-specific transfusion and cyclosporin A administered 24 to 48 hours before one-haplotype-mismatched living related donor kidney transplant.
    Davies CB, Alexander JW, Cofer BR, First MR, Schroeder TJ.
    Ann Surg; 1992 Jun; 215(6):618-25; discussion 626. PubMed ID: 1632683
    [Abstract] [Full Text] [Related]

  • 26. Enhancement of allograft survival by donor-specific transfusion one day prior to transplant. Importance of timing and specificity when DST is given with cyclosporine.
    Brunson ME, Tchervenkov JI, Alexander JW.
    Transplantation; 1991 Sep; 52(3):545-9. PubMed ID: 1716800
    [Abstract] [Full Text] [Related]

  • 27. Multivariate analysis of donor-specific versus random transfusion protocols in haploidentical living-related transplants.
    Reed A, Pirsch J, Armbrust MJ, Burlingham WJ, Knechtle SJ, D'Alessandro AM, Sollinger HW, Lorentzen D, Kalayoglu M, Belzer FO.
    Transplantation; 1991 Feb; 51(2):382-4. PubMed ID: 1994532
    [Abstract] [Full Text] [Related]

  • 28. Effect of sex on kidney transplants.
    Zhou YC, Cecka JM.
    Clin Transpl; 1989 Feb; ():361-7. PubMed ID: 2487604
    [Abstract] [Full Text] [Related]

  • 29. Kidney retransplantation in the cyclosporine era.
    Stratta RJ, Oh CS, Sollinger HW, Pirsch JD, Kalayoglu M, Belzer FO.
    Transplantation; 1988 Jan; 45(1):40-5. PubMed ID: 3276060
    [Abstract] [Full Text] [Related]

  • 30. The induction of immunologic hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. A preliminary trial.
    Alexander JW, Babcock GF, First MR, Davies CB, Madden RL, Munda R, Penn I, Fidler JP, Cofer BR, Stephens G.
    Transplantation; 1992 Feb; 53(2):423-7. PubMed ID: 1371197
    [Abstract] [Full Text] [Related]

  • 31. The changing role of HLA matching.
    Cecka JM.
    Clin Transpl; 1986 Feb; ():141-55. PubMed ID: 3154392
    [Abstract] [Full Text] [Related]

  • 32. The transfusion effect.
    Cecka JM.
    Clin Transpl; 1987 Feb; ():287-301. PubMed ID: 3154420
    [Abstract] [Full Text] [Related]

  • 33. Randomized clinical trial of cyclosporine or donor specific transfusions in high risk living-related donor transplantation.
    Bordes-Aznar J, Odor A, Dib-Kuri A, Gabilondo F, Kasep J, Peña JC, Herrera-Acosta J, Chávez-Peón F.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2276-7. PubMed ID: 3079080
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Induction of donor-specific immune modulation and successful renal transplantation with a simplified method of donor-specific blood transfusion.
    Cheigh JS, Suthanthiran M, Fotino M, Kaplan M, Evelyn M, Schechter N, Wolf CF, Riggio RR, Riehle R, Stubenbord WT.
    Uremia Invest; 1987 Feb; 9(1):11-7. PubMed ID: 2940741
    [Abstract] [Full Text] [Related]

  • 36. Evidence that HLA class II disparity is required for the induction of renal allograft enhancement by donor-specific blood transfusions in man.
    Lazda VA, Pollak R, Mozes MF, Barber PL, Jonasson O.
    Transplantation; 1990 Jun; 49(6):1084-7. PubMed ID: 2360251
    [Abstract] [Full Text] [Related]

  • 37. Renal transplantation from HLA-haploidentical living-related donors: the effects of donor-specific blood transfusions and different immunosuppressive regimens.
    Sakagami K, Saito S, Shiozaki S, Fujiwara T, Haisa M, Niguma T, Kusaka S, Uda M, Matsuno T, Takasu S.
    Acta Med Okayama; 1992 Feb; 46(1):1-5. PubMed ID: 1561899
    [Abstract] [Full Text] [Related]

  • 38. Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates.
    Ringers J, Haanstra KG, Kroczek RA, Kliem K, Kuhn EM, Wubben J, Ossevoort MA, Volk HD, Jonker M.
    Transplantation; 2002 Mar 27; 73(6):862-6. PubMed ID: 11923684
    [Abstract] [Full Text] [Related]

  • 39. A four-year experience with donor blood transfusion protocols for living-donor renal transplantation.
    Glass NR, Miller DT, Sollinger HW, Belzer FO.
    Transplantation; 1985 Jun 27; 39(6):615-9. PubMed ID: 3890291
    [Abstract] [Full Text] [Related]

  • 40. Improved renal allograft survival following donor-specific transfusions. II. In vitro correlates of early (DST-type) rejection episodes.
    Burlingham WJ, Grailer A, Sparks-Mackety EM, Sondel PM, Sollinger HW.
    Transplantation; 1987 Jan 27; 43(1):41-6. PubMed ID: 2948309
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.